Stéphane Holbrechts

743 total citations
29 papers, 403 citations indexed

About

Stéphane Holbrechts is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stéphane Holbrechts has authored 29 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Stéphane Holbrechts's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Colorectal Cancer Surgical Treatments (4 papers). Stéphane Holbrechts is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Colorectal Cancer Surgical Treatments (4 papers). Stéphane Holbrechts collaborates with scholars based in Belgium, France and United States. Stéphane Holbrechts's co-authors include Marianne Paesmans, Marc Peeters, Alain Hendlisz, Amélie Deleporte, Anne‐Pascale Meert, Thierry Berghmans, Raphaël Maréchal, Valérie Durieux, Anne Demols and Stéphanie Laurent and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Respiratory Journal.

In The Last Decade

Stéphane Holbrechts

27 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Holbrechts Belgium 9 217 142 112 68 63 29 403
Jialong Li China 9 111 0.5× 99 0.7× 131 1.2× 49 0.7× 28 0.4× 34 345
Masahiro Mitsuoka Japan 15 193 0.9× 236 1.7× 325 2.9× 124 1.8× 19 0.3× 54 660
André Lollert Germany 12 176 0.8× 205 1.4× 69 0.6× 21 0.3× 37 0.6× 29 443
Raj Singh United States 11 177 0.8× 111 0.8× 266 2.4× 50 0.7× 13 0.2× 50 485
M. Rossi Italy 11 239 1.1× 161 1.1× 253 2.3× 22 0.3× 51 0.8× 20 458
Başak Oyan Türkiye 12 155 0.7× 54 0.4× 92 0.8× 25 0.4× 17 0.3× 39 348
Deborah Zihler Switzerland 8 209 1.0× 111 0.8× 75 0.7× 24 0.4× 21 0.3× 15 374
Haruaki Hino Japan 11 106 0.5× 123 0.9× 214 1.9× 18 0.3× 33 0.5× 59 382
Stefano Margaritora Italy 13 175 0.8× 129 0.9× 311 2.8× 69 1.0× 11 0.2× 75 513

Countries citing papers authored by Stéphane Holbrechts

Since Specialization
Citations

This map shows the geographic impact of Stéphane Holbrechts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Holbrechts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Holbrechts more than expected).

Fields of papers citing papers by Stéphane Holbrechts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Holbrechts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Holbrechts. The network helps show where Stéphane Holbrechts may publish in the future.

Co-authorship network of co-authors of Stéphane Holbrechts

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Holbrechts. A scholar is included among the top collaborators of Stéphane Holbrechts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Holbrechts. Stéphane Holbrechts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wery, Didier, et al.. (2021). Antiphospholipid syndrome-induced ischemic stroke following pembrolizumab: Case report and systematic review. Lung Cancer. 160. 59–65. 7 indexed citations
2.
Demols, Anne, Ivan Borbath, Marc Van den Eynde, et al.. (2020). Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial. Annals of Oncology. 31(9). 1169–1177. 78 indexed citations
3.
4.
Bregni, Giacomo, Tuğba Akın Telli, Silvia Camera, et al.. (2019). Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice. Cancer Treatment Reviews. 83. 101948–101948. 56 indexed citations
5.
Vandeputte, Caroline, Lieveke Ameye, Thomas Guiot, et al.. (2019). Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials. BMC Cancer. 19(1). 134–134. 79 indexed citations
6.
Joris, Sofie, Thierry Pieters, Anne Sibille, et al.. (2019). Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program. Journal of Geriatric Oncology. 11(5). 796–801. 9 indexed citations
7.
Vandeputte, Caroline, Lieveke Ameye, Hakim El Housni, et al.. (2018). High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib.. Journal of Clinical Oncology. 36(15_suppl). 3532–3532. 2 indexed citations
8.
Holbrechts, Stéphane, et al.. (2017). Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature. Lung Cancer. 106. 93–101. 6 indexed citations
9.
10.
Sculier, Claudine, Bogdan Grigoriu, Spyridon Sideris, et al.. (2017). Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions. Lung Cancer. 111. 164–175. 9 indexed citations
11.
Hendlisz, Alain, Camilo Garcia, Amélie Deleporte, et al.. (2016). Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 43(10). 1792–1801. 14 indexed citations
12.
Heuvel, Bert van den, Marc Peeters, Alain Hendlisz, et al.. (2016). Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.. PubMed. 3 indexed citations
13.
Holbrechts, Stéphane, et al.. (2014). [Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].. PubMed. 35(3). 160–3.
14.
Berghmans, Thierry, Antoine Cortot, Bogdan Grigoriu, et al.. (2014). Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 35(3). 132–133. 1 indexed citations
15.
Berghmans, Thierry, Alexis B. Cortot, Bogdan Grigoriu, et al.. (2014). [Guidelines of clinical practice made by the European Lung Cancer Working Party: updates].. PubMed. 35(3). 132–3. 1 indexed citations
16.
Paesmans, Marianne, Bogdan Grigoriu, Sebahat Ocak, et al.. (2014). Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design. European Respiratory Journal. 45(2). 511–524. 6 indexed citations
17.
Holbrechts, Stéphane, et al.. (2014). Primitive Pulmonary “Malignant Epithelioid Hemangioendothelioma” versus Epithelioid Angiosarcoma A Case Report and Review of the Literature. Acta chirurgica Belgica. 114(2). 143–145. 4 indexed citations
18.
Deleporte, Amélie, Alain Hendlisz, Raphaël Maréchal, et al.. (2012). Somore Trial: Combining Sorafenib (SOR) with Capecitabine (CAP) Yields Highly Encouraging Survival Results and Elevated Metabolic Response Rate in Chemorefractory Metastatic Colorectal Cancer (MCRC). Annals of Oncology. 23. ix194–ix194. 2 indexed citations
19.
Holbrechts, Stéphane & Martine Roelandts. (2008). Traitement du cancer bronchique à petites cellules : maladies limitées. Recommandations de pratique clinique de l'European Cancer Working Party.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 29(3). 160–163.
20.
Berghmans, Thierry, P. Van Houtte, Marianne Paesmans, et al.. (2008). A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. Lung Cancer. 64(2). 187–193. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jialong Li Breakdown of academic impact, for papers by Masahiro Mitsuoka Breakdown of academic impact, for papers by André Lollert Breakdown of academic impact, for papers by Raj Singh Breakdown of academic impact, for papers by M. Rossi Breakdown of academic impact, for papers by Başak Oyan Breakdown of academic impact, for papers by Deborah Zihler Breakdown of academic impact, for papers by Haruaki Hino Breakdown of academic impact, for papers by Stefano Margaritora
Rankless by CCL
2026